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Pulmonary alveolar type I (AT1) cells cover more than 95% of
alveolar surface and are essential for the air–blood barrier function
of lungs. AT1 cells have been shown to retain developmental plas-
ticity during alveolar regeneration. However, the development
and heterogeneity of AT1 cells remain largely unknown. Here, we
conducted a single-cell RNA-seq analysis to characterize postnatal
AT1 cell development and identified insulin-like growth factor-
binding protein 2 (Igfbp2) as a genetic marker specifically expressed
in postnatal AT1 cells. The portion of AT1 cells expressing Igfbp2
increases during alveologenesis and in post pneumonectomy (PNX)
newly formed alveoli. We found that the adult AT1 cell population
contains both Hopx+Igfbp2+ and Hopx+Igfbp2− AT1 cells, which have
distinct cell fates during alveolar regeneration. Using an Igfbp2-CreER
mouse model, we demonstrate that Hopx+Igfbp2+ AT1 cells repre-
sent terminally differentiated AT1 cells that are not able to transdif-
ferentiate into AT2 cells during post-PNX alveolar regeneration. Our
study provides tools and insights that will guide future investigations
into the molecular and cellular mechanism or mechanisms underlying
AT1 cell fate during lung development and regeneration.
pulmonary alveolar type I cells | single cell RNA-seq | alveolar
development and regeneration | Igfbp2 | lineage tracing
The pulmonary alveolar epithelium is not only essential forlung gas-exchange function but also functions as an important
barrier to protect our body from hazards. In response to acute
injuries, pulmonary alveoli are able to quickly repair and re-
generate new alveolar epithelial cells for restoring an intact epi-
thelial barrier. The pulmonary alveolar epithelium is mainly
composed of two types of epithelial cells: alveolar type I (AT1)
and type II (AT2) cells. AT2 cells are smaller, cuboidal cells that
are best known for their functions in synthesizing and secreting
pulmonary surfactant. In addition, AT2 cells serve as alveolar stem
cells and can differentiate into AT1 cells during alveolar homeo-
stasis and post injury repair (1–3). AT1 cells are large squamous
cells that cover 95% of the alveolar surface area and form the
epithelial component of the thin air–blood barrier (4, 5).
At the late embryonic stage, both AT1 and AT2 cells differ-
entiate from alveolar progenitor cells and form distal epithelial
saccules (6, 7). After birth, the epithelial saccules are continu-
ously subdivided into numerous smaller mature gas-exchange
units called alveoli. This postnatal developmental process is called
alveologenesis, which occurs with 90% of human alveoli and all
mouse alveoli (8). During alveologenesis, AT1 cells expand their
surface area and flatten their cell body to accommodate postnatal
lung growth (9). AT1 cells were traditionally considered to be
terminally differentiated cells. However, an exciting recent study
found that adult AT1 cells retain cellular plasticity and are able to
proliferate and give rise to AT2 cells during post-PNX alveolar
regeneration (10).
Although a long series of studies has greatly advanced our
knowledge of AT1 cells during alveolar development and re-
generation (4, 9–18), we still know little about the molecular
genetics and fate specification of AT1 cells. Because of the lack
of knowledge of the development and heterogeneity of adult
AT1 cell population, it is unclear whether all or only a subset of
AT1 cells can transdifferentiate into AT2 cells during alveolar
regeneration (9, 10). In addition, AT1 cell development during
alveologenesis is still poorly characterized at the transcriptome
level because of the difficulty of isolating these fragile cells.
Here, we applied a combination of single-cell RNA-seq analysis,
mouse genetics, and alveolar-like organoid cultures and charac-
terized AT1 cell development during both postnatal lung devel-
opment and alveolar regeneration. We identified a genetic marker
of postnatal AT1 cells, insulin-like growth factor-binding protein 2
(Igfbp2), and use this marker to demonstrate that the postnatal
AT1 cell population contains two unevenly distributed AT1 cell
subtypes, Hopx+Igfbp2+ and Hopx+Igfbp2− AT1 cells. Igfbp2 is
heterogeneously expressed in AT1 cells of newborn lungs and
newly differentiated AT1 cells (from AT2 cells) that occur during
post-PNX alveolar regeneration. Importantly, we demonstrate
that Hopx+Igfbp2+ AT1 cells maintain their AT1 cell fate and do
not transdifferentiate into AT2 cells in normal or post injury lungs.
Therefore, Hopx+Igfbp2+ AT1 cells represent the terminally dif-
ferentiated population of AT1 cells.
Significance
Pulmonary alveolar type I (AT1) cells are essential for the gas-
exchange function of lungs. AT1 cells retain their cellular plas-
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Results
Overview of Developmental Changes of Postnatal AT1 Cells at the
Single-Cell Level. To gain a comprehensive understanding of post-
natal AT1 cell development, we performed single-cell RNA-seq
(scRNA-seq) analyses of AT1 cells at postnatal day 3 (P3), P15,
and P60. We selected these times because alveologenesis in mice is
known to begin at P4, and secondary septation formation is typi-
cally completed before P15 (15, 19–21).
We set up a strategy to sort AT1 cells and to avoid the contam-
ination of AT2 cells by generating Sftpc-CreER; Rosa26-Zsgreen;
Hopx-tdTomato mice (Fig. 1A and SI Appendix, Fig. S1 A–D). Lungs
of TAM-treated Sftpc-CreER; Rosa26-Zsgreen; Hopx-tdTomato
mice at P3, P15, and P60 were dissociated in an enzymatic mixture
solution (Fig. 1A) (10). Single-cell suspensions were sorted by FACS
to enrich cells expressing both RFP and Pdpn and to deplete GFP+
AT2 cells, RFP+Pdpn− ciliated cells, and CD45+ cells (Fig. 1A and
SI Appendix, Fig. S1 E and F). RFP+Pdpn+GFP−CD45− cells were
then analyzed with scRNA-seq. After filtering, normalization, and
removal of potential outliers (SI Appendix, SI Materials and Methods),
3,149 cells from P3 lungs, 2,940 cells from P15 lungs, and 1,337 cells
from P60 lungs that had high gene expression signals were used for
subsequent analyses (Fig. 1 B–D and Dataset S1).
A t-distributed stochastic neighbor embedding (tSNE)-based plot
revealed that cells from P3, P15, and P60 lungs can be clustered into
four, four, and two main distinct populations, respectively (Fig. 1 B–
D). Cells of the largest of the populations express high levels of
classic AT1 cell markers such as Hopx, Pdpn, and Ager, but have
low-level expression of classic AT2 markers such as Sftpb, Sftpc, and
Sftpd; ciliated cell marker Foxj1; and the endothelial cell marker
Pecam1 (SI Appendix, Fig. S2 A–C), indicating these cells are
AT1 cells. We also used scRNA-seq to identify genes that are
specifically expressed in small cell populations. Our results from
this analysis revealed several types of expression signatures
(Dataset S1) (22), which strongly suggested that there were three
distinct cells populations that could be contaminated by AT1 cell
debris (SI Appendix, Fig. S1G): endothelial cells, ciliated cells, and
AT2 cells. Thus, we excluded these populations when we per-
formed our hierarchical clustering analysis of gene expression for
cells of the largest cell population (AT1 cells).
Using the clustering analysis, differentially expressed genes were
clustered into five groups according to their expression patterns
among P3, P15, and P60 AT1 cells (Fig. 2A and Dataset S2). The
expression levels of genes in group I significantly decreased during
postnatal AT1 cell development (Fig. 2A). We performed gene
ontology (GO) and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway enrichment analyses to determine enriched
terms of genes in group I. Many genes in the group I are known to
regulate pluripotency of stem cells (Id1, Id2, and Id3) (23, 24), cell
cycle (Cdkn1a) (25), and translation (Rpl5) (26) (Fig. 2 B and C
and Dataset S3), indicating that postnatal AT1 cells continue to
differentiate during alveologenesis. The expression levels of genes
in group II are higher at P15 than at P3 or P60 (Fig. 2A). Genes in
group II are known to regulate the epidermal growth factor re-
ceptor signaling pathway (Rhbdf1) and angiogenesis (Klf2 and
Cdh13) (Dataset S3). The expression levels of genes in groups III,
IV, and V significantly increased during postnatal AT1 cell de-
velopment (Fig. 2A). Genes in these three groups are highly
enriched for regulating cell growth (Igfbp2) (27), dendrite and
neuron projection development (Bdnf) (28), exogenous drug cat-
abolic process (Cyp4b1 and Cyp2b10) (29), and angiogenesis (Ctgf)
(30) (Fig. 2 B′ and D and Dataset S3).
Our single-cell analysis offers unprecedentedly high resolution
to define the specificity and temporal expression patterns of
genes expressed in postnatal AT1 cells. This allows us to identify
biomarkers that are specifically expressed in adult AT1 cells. We
compared the scRNA-seq profiles between AT1 and AT2 cells of
P60 lungs (SI Appendix, Fig. S3). AT2 cells (GFP+CD45−) were
isolated from the same lungs of Sftpc-CreER; Rosa26-Zsgreen;
Hopx-tdTomato mice that we used for P60 AT1 cell scRNA-seq
analysis (SI Appendix, Fig. S3A). After removing the potential
outliers, 2,093 cells with high gene expression levels of Sftpb,
Sftpc, Sftpd, and Cxcl15 were extracted for the AT2 cell scRNA-
seq analysis (SI Appendix, Fig. S3 B and C and Dataset S1). The
GO and KEGG pathway enrichment analyses show that genes up-
regulated in AT1 cells mainly function in regulating cell shape, cell
adhesion, cytoskeleton, and angiogenesis (SI Appendix, Fig. S3D
and Dataset S4). By comparing the gene expression between
AT1 and AT2 cells by both scRNA-seq analysis and quantitative
real-time PCR analysis, we identified many specific biomarkers of
adult AT1 and AT2 cells that have not been previously described
(SI Appendix, Fig. S4 and Dataset S5).
The Portion of AT1 Cells Expressing Igfbp2 Gradually Increases During
Postnatal Lung Development. Among the previously characterized
and newly identified AT1 cell markers, we found that Igfbp2 is
one of the most specific biomarker genes of adult AT1 cells (SI
Appendix, Fig. S4 A and C). Interestingly, the portion of cells
expressing Igfbp2 increases during postnatal AT1 cell develop-
ment (Fig. 2D and SI Appendix, Fig. S2D), whereas classic AT1
biomarker genes such as Pdpn, Hopx, Aqp5, and Ager are invariantly
expressed in almost all AT1 cells during postnatal AT1 cell devel-
opment (SI Appendix, Fig. S2D). We performed immunostaining
experiments using an anti-Igfbp2 antibody to validate the expression
of Igfbp2 in prenatal and postnatal AT1 cells (Fig. 3 A and B and SI
Appendix, Fig. S5 A and B). Unlike classic AT1 cell markers such as
Pdpn, Hopx, Aqp5, and Ager that are expressed in AT1 cells starting
from embryonic (E) 16.5 (6, 10, 22), Igfbp2 is not expressed in
AT1 cells until P1. At P1, fewer than 20% of Hopx+ AT1 cells are
positive for Igfbp2 expression. Within 15 d after birth, however, the
percentage of Hopx+Igfbp2+ AT1 cells increases to 85%. By P60,
95% of the Hopx+ AT1 cells are positive for Igfbp2 expression.
Importantly, there is a small subset of Hopx+ AT1 cells (less than
5%) that does not express Igfbp2 at P60 (SI Appendix, Fig. S5B;
n = 5 mice; total, 1,958 cells). This immunostaining result is
consistent with our scRNA-seq result for P60 lungs, which showed
that 5% Hopx+ AT1 cells do not express Igfbp2 (SI Appendix,
Fig. S2D). Note that no Igfbp2 protein expression was detected
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Fig. 1. Analyze the development of postnatal AT1 cells by single-cell RNA-
seq (scRNA-seq). (A) Schematic illustration of the strategy of lung dissocia-
tion, AT1 cell sorting, and single-cell RNA sequencing analysis. (B–D)
RFP+Pdpn+GFP−CD45− cells were isolated from TAM-treated Sftpc-CreER;
Rosa26-Zsgreen; Hopx-tdTomato mice at P3 (B), P15 (C), and P60 (D). The
t-distributed stochastic neighbor embedding plots show cells isolated from P3
(B), P15 (C), and P60 (D) lungs can be clustered into four, four, and two main
distinct populations, respectively. AT1 cell population is characterized by
expressing Hopx and Pdpn (AT1 markers), but not Sftpc (AT2 marker), Pecam1
(endothelial cell marker), and Foxj1 (ciliated cell marker).
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in any of the P60 AT2 cells (SI Appendix, Fig. S5 C and D; n =
5 mice; total, 3,377 cells) and club cells (SI Appendix, Fig. S5 E
and F; n = 5 mice; total, 2,691 cells). We also investigate whether
IGFBP2 is expressed in adult human AT1 cells. We found that
IGFBP2 is also specifically expressed in adult human AT1 cells
(SI Appendix, Fig. S5G). Therefore, IGFBP2 is a specific AT1 cell
marker in both human AT1 cells and mouse AT1 cells.
Our observation of the differential expression of Igfbp2 promp-
ted us to examine our scRNA-seq data set to identify other dif-
ferences in the transcriptomes between Igfbp2+ and Igfbp2− AT1
cells during alveologenesis. Specifically, at the individual cell level,
Igfbp2 can be detected in 62% of Hopx+ AT1 cells at P3, 85% of
Hopx+AT1 cells at P15, and 94%Hopx+AT1 cells at P60 (Fig. 3 B
and C and SI Appendix, Fig. S2D–F). A GO analysis of the 32 genes
that are consistently up-regulated in Igfbp2+ AT1 cells among P3,
P15, and P60 lungs revealed strong enrichment for the following
terms: regulation of cell growth, angiogenesis, extracellular matrix
organization, positive regulation of cell migration, and patterning of
blood vessels (Fig. 3D and Dataset S6). Moreover, GO analysis of the
31 genes that are consistently up-regulated in Igfbp2− AT1 cells
revealed strong enrichment for the following terms: translation, reg-
ulation of cell cycle, and epithelial cell differentiation (Dataset S7). In
addition, the expression level of Sftpd is significantly increased in
Igfbp2− AT1 cells compared with Igfbp2+ AT1 cells. These results
support our findings that the expression of Igfbp2 is positively asso-
ciated with AT1 cell development during alveologenesis.
Igfbp2 Is a Late AT1 Cell Marker During Post Injury Alveolar Regeneration.
Our result that the expression of Igfbp2 is associated with AT1 cell
development prompted us to investigate the expression of Igfbp2 in
newly differentiated AT1 cells that occur during alveolar regenera-
tion. We therefore investigate the expression of Igfbp2 in newly
regenerated alveoli, using a PNX-induced alveolar regeneration
mouse model (10, 31).
We used Sftpc-CreER mice and Rosa26-mTmG reporter al-
leles for lineage labeling AT2 cells to track the differentiation of
AT2 cells into AT1 cells. We performed a PNX treatment on
Sftpc-CreER; Rosa26-mTmG mice and collected lungs for
analysis at post-PNX day 14, 21, and 45 (Fig. 3 E–H). By post-
PNX day 14, many lineage-labeled AT2 cells had differentiated
into AT1 cells that express Hopx, Ager, and Aqp5 (SI Appendix,
Fig. S5 H and I); notably, these newly differentiated cells did not
express Igfbp2 (Fig. 3 F and H). The percentage of Hopx+ AT1
cells expressing Igfbp2 increases over time. By post-PNX day
45, most of the post-PNX differentiated Hopx+ AT1 cells were
expressing Igfbp2 (Fig. 3 G and H).
We also monitored Igfbp2 expression in experiments with 3D
alveolar-like organoids (1). Lineage-labeled AT2 cells from
TAM-treated Sftpc-CreER; Rosa26-Zsgreen mice were isolated
by FACS and plated in culture medium with 50% Matrigel in
Transwell cell culture inserts, as previously described (Fig. 3I)
(1). At day 9 post plating of the culture, we started to observe
some flattened cells in the interior luminal side of the organoids
that expressed Hopx, but did not express Igfbp2 (Fig. 3 J, K, and
N). By day 14 post plating of the culture, 30% of the Hopx+
AT1 cells were expressing Igfbp2 (Fig. 3 L–N). Similar to what we
observed in our analysis of post-PNX lungs, the ratio of
Hopx+Igfbp2+ cells to Hopx+ cells increases over time (Fig. 3N).
Collectively, our extensive in vivo and in vitro organoid results
support that the expression of Igfbp2 is later than the expression of
Hopx for newly differentiated AT1 cells during alveolar regeneration.
Igfbp2+ AT1 Cells Maintain Their AT1 Cell Fate During Alveologenesis.
We showed two Igfbp2 expression patterns in postnatal and post-
PNX AT1 cells (Fig. 3 A, B, and F–H). Previous studies have
established that Hopx+ alveolar epithelial cells are able to become
both AT1 and AT2 cells during the first month of postnatal life (10),
immediately raising a question about the fate of Igfbp2+ cells during
alveologenesis. To specifically label Igfbp2+ AT1 cells, we generated
an Igfbp2-CreER knock-in allele (SI Appendix, Fig. S6A). We first
performed a short-term lineage tracing experiment to validate the
expression of Igfbp2 in adult lungs (Fig. 4A). About 84 ∼ 90% of the
Hopx+ AT1 cells (n = 5 mice; total, 3,158 cells) were lineage labeled
(Fig. 4 B and C), and none of Prospc+ cells (n = 5 mice; total,
5,127 cells) or Scgb1a1+ cells (n = 5 mice; total, 3,565 cells) expressed
any GFP (Fig. 4 D and E and SI Appendix, Fig. S6 B and C).
Igfbp2-CreER, Rosa26-tdTomato pups were given one TAM
injection at P5, and lungs were collected for analysis 24 h later, at
P30, or at P336 (Fig. 4F and SI Appendix, Fig. S6D). At P6, about
65% Hopx+ of the AT1 cells were lineage-labeled (SI Appendix,
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Fig. S6 E and F; n = 3 mice), all of which were Pdpn+ AT1 cells
(Fig. 4G). There were still 65–70% lineage-labeled Hopx+
AT1 cells present in the lungs at P30 and at P336 (SI Appendix,
Fig. S6 E and F). We also did not detect any AT2 cells or club
cells expressing RFP at any of the sampled times from P6 to
P336 (Fig. 4G and H and SI Appendix, Fig. S6G). In addition, we
found that these lineage-labeled AT1 cells were still expressing
Igfbp2 in lungs at P336 post-TAM injection (Fig. 4I), revealing that
these Igfbp2 lineage-labeled AT1 cells maintain their Igfbp2 ex-
pression, and suggesting that the turnover of the Igfbp2+ AT1 cells
is slow in the steady-state condition.
Igfbp2+ AT1 Cells Are Terminally Differentiated AT1 Cells During PNX-
Induced Alveolar Regeneration. It was shown that adult Hopx+ AT1
cells are able to transdifferentiate into AT2 cells, and thereby
contribute to lung regrowth during post-PNX alveolar regeneration
(10, 31). Our characterization of the two distinct AT1 cell subtypes
in Hopx+ AT1 cells motivated us to investigate whether a bi-
directional lineage relationship exists between Igfbp2+ AT1 cells
and AT2 cells during PNX-induced alveolar regeneration.
We gave Igfbp2-CreER; Rosa26-Zsgreen mice four doses of
TAM to label Igfbp2+ AT1 cells, and performed a left lung re-
section (Fig. 5A). At 26 d after PNX treatment, we collected
lungs from PNX-treated mice (n = 5 mice each group). In PNX-
treated lungs, more than 85% of Hopx+ AT1 cells were lineage
labeled, and all the GFP+ cells were Hopx+ AT1 cells (Fig. 5B).
Among all the lungs examined, no GFP lineage-labeled cells
expressed Prospc or Scgb1a1 (Fig. 5B and SI Appendix, Fig.
S7A). These results indicate that Igfbp2+ AT1 cells cannot
transdifferentiate into AT2 cells or club cells after PNX treatment.
Furthermore, we found that no Igfbp2+ AT1 cells expressed Ki67
during alveolar development or during PNX-induced alveolar
regeneration (SI Appendix, Table S1), indicating that Igfbp2+ AT1
cells cannot proliferate in vivo.
We further investigated the clonal formation capacity of Hopx+
AT1 cells and Igfbp2+ AT1 cells in a 3D organoid culture system.
Sftpc-CreER; Rosa26-Zsgreen; Hopx-tdTomato mice were treated
with four doses of TAM to label AT2 cells. Three days after the
last dose of TAM treatment, 5 × 104 Hopx+Pdpn+ AT1 cells
(RFP+Pdpn+GFP−CD45−) were isolated by FACS and plated in a
3D organoid culture system (Fig. 5C). Consistent with a previous
finding (10), many GFP− organoids that contain both Hopx+
AT1 cells and Prospc+ AT2 cells had formed by day 14 (Fig. 5 D
and E and SI Appendix, Fig. S7B). Many flattened Hopx+ cells in
the interior luminal side of the organoids expressed Igfbp2 (Fig.
5E). Recall that we showed that AT1 cells express Hopx, but not
Igfbp2, at post plating day 9 (Fig. 3K). Therefore, we first cultured
lineage-labeled GFP+ AT2 cells isolated from Sftpc-CreER;
Rosa26-Zsgreen; Hopx-tdTomato mice. At post plating day 9, we
isolated GFP+Hopx+Pdpn+ AT1 cells (Fig. 5 F and G) and cul-
tured these GFP+Hopx+Pdpn+ AT1 cells in a 3D organoid culture
system. We found that by post plating day 14, these organoids
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analyzed by antibodies against GFP, Igfbp2, and Hopx. Arrowheads indicate the original AT1 cells. Arrows indicate newly differentiated AT1 cells. The percentages
(mean ± SEM, n = 3) of newly differentiated AT1 cells expressing Igfbp2 in all newly differentiated AT1 cells are quantified (H). (I–N) Organoids grown from
lineage-labeled AT2 cells (I) were collected at post plating day 9 (J) and day 14 (L) and stained with antibodies against Igfbp2 and Hopx (K andM). The proportion
(mean ± SEM, n = 3) of Hopx+Igfbp2+ cells among the Hopx+ cells was quantified. (Scale bars: A, F, G, K, and M, 25 μm; J and L, 1 mm.)
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contained both Hopx+Igfbp2+ AT1 cells and Prospc+ AT2 cells
(Fig. 5H and SI Appendix, Fig. S7C). Beyond highlighting the cel-
lular plasticity of these Hopx+Igfbp2−AT1 cells, these results show
that Igfbp2+ AT1 cells are derived from Hopx+Igfbp2− AT1 cells.
In a parallel experimental approach, we labeled Igfbp2+ AT1 cells
by injecting four doses of TAM to Igfbp2-CreER; Rosa26-tdTomato
mice. Three days after the last dose of TAM treatment, 5 × 104
Igfbp2+ AT1 cells (RFP+Pdpn+CD45−) were isolated by FACS
and plated in a 3D organoid culture system (Fig. 5I). We saw no
RFP+ organoid formation by day 14 of culture (n = 6 experiments)
(Fig. 5 J and K). To monitor the conditions of our organoid culture
system, we isolated AT2 cells (GFP+CD45−) from TAM-treated
Sftpc-CreER; Rosa26-mTmG mice and Igfbp2+ AT1 cells
(RFP+Pdpn+CD45−) from TAM-treated Igfbp2-CreER; Rosa26-
tdTomato mice (SI Appendix, Fig. S7D). We then mixed 5,000
AT2 cells (GFP+CD45−) with 5 × 104 Igfbp2+ AT1 cells (RFP+
Pdpn+CD45−) in the same Transwell cell culture insert (SI Appendix,
Fig. S7D). Many organoids had formed by day 14. All the clones
expressed GFP, but not RFP (SI Appendix, Fig. S7 E–G), indicating
that these clones were generated from AT2 cells but not Igfbp2+
AT1 cells. Both our in vivo and in vitro results demonstrated that
Hopx+Igfbp2+ AT1 cells are terminally differentiated AT1 cells that
cannot proliferate and transdifferentiate into AT2 cells.
Discussion
In this study, we characterized the developmental changes of
AT1 cells during alveologenesis and alveolar regeneration. Our
study revealed that the adult AT1 cell population contains two
distinct types of cells: Hopx+Igfbp2+ and Hopx+Igfbp2− AT1
cells. Adult Hopx+Igfbp2+ AT1 cells represent the large majority
of Hopx+ AT1 cells and are terminally differentiated; that is,
they cannot transdifferentiate into AT2 cells and cannot pro-
liferate during alveolar regeneration. Hopx+Igfbp2− AT1 cells,
which account for fewer than 5% of the Hopx+ AT1 cells in adult
lungs, contain cell populations that maintain cellular plasticity
and can generate alveolar-like organoids. Both a post-PNX alve-
olar regeneration mouse model and in vitro organoid culture re-
sults show that Igfbp2 expression occurs later than Hopx
expression in AT1 cells that have differentiated from AT2 cells.
Notably, organoids generated from Hopx+ AT1 cells contain both
Hopx+Igfbp2+ and Hopx+Igfbp2− AT1 cells. Consideration of
these multiple lines of evidence lead us to speculate that Hopx+
Igfbp2− AT1 cells in normal adult lungs seem to represent an
intermediate stage of AT1 cell differentiation during the ongoing
physiological renewal of the alveolar epithelium. Some of these
newly differentiated Hopx+Igfbp2− AT1 cells likely to maintain
developmental plasticity in the period before these cells begin to
express Igfbp2; these Hopx+Igfbp2− cells can transdifferentiate
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bars: B, D, and G–I, 25 μm.)
H day14
Igfbp2
Hopx
DAPI
260-7-9-11-13
PNXA
(days)
Igfbp2-CreER; Rosa26-Zsgreen
TAM analysis
C D
GFP &
brightfield
Sftpc-CreER; 
Rosa26-Zsgreen; 
Hopx-tdTomato
GFP &
brightfield
F
RFP+GFP+Pdpn+
5X104 Hopx+ AT1 
cells cultured 
for 14 days
I
Igfbp2-CreER; 
Rosa26-tdTomato
5X104 Igfbp2+
AT1 cells cultured 
for 14 days
RFP+Pdpn+CD45-  
J
RFP
K
brightfield
B
GFP
DAPI
Hopx
DAPI
Prospc
DAPI
5X104 Hopx+ AT1 cells 
cultured 
for 14 days
5X103 GFP+ AT2 cells
cultured 
for 9 days
 day 9 alveolar-like 
organoids grown from 
GFP+ AT2 cells
RFP+Pdpn+
GFP-CD45-  
RFP-GFP+CD45- 
E day 14
Igfbp2
Hopx
DAPI
G day 9
GFP
Hopx
Pdpn
DAPI
Fig. 5. Igfbp2+ AT1 cells are terminal differentiated AT1 cells and can dif-
ferentiated from Hopx+ AT1 cells. (A–C) Lungs of PNX-treated Igfbp2-CreER;
Rosa26-Zsgreen mice (A) were analyzed with antibodies against GFP, Hopx,
and Prospc (B). (C) Organoids were grown from either Hopx+ AT1 cells or
GFP+ lineage-labeled AT2 cells. (D and E) At post plating day 14, organoids
growth Hopx+ AT1 cells (D) from were analyzed with antibodies against
Igfbp2 and Hopx (E). (F–H) At post plating day 9, some flatten cells at the
luminal side of organoids formed from GFP+ AT2 cells (F) expressed both
Hopx and Pdpn (G). Hopx+ cells were then isolated from these day 9 organoids
and cultured in a 3D organoid culture system. At post plating day 14, some
Hopx+ AT1 cells expressed Igfbp2 (H). (I–K ) Lineage-labeled Igfbp2+
AT1 cells were plated for the alveolar organoid culture (I). No RFP+ organoids
formed by day 14 of culture (J and K). (Scale bars: B, E, G, and H, 25 μm; D, F, J,
and K, 1 mm.)
Wang et al. PNAS | March 6, 2018 | vol. 115 | no. 10 | 2411
D
EV
EL
O
PM
EN
TA
L
BI
O
LO
G
Y
into AT2 cells, and thus help maintain tissue integrity in the
context of repair during injury-induced alveolar regeneration.
Our scRNA-seq analysis shows that postnatal AT1 cells con-
tinue to differentiate and enhance their functions in air–blood
barrier and alveolar angiogenesis during postnatal lung develop-
ment. Compared with AT1 cells in neonatal mice, adult AT1 cells
are much larger, squamous cells with thin cytoplasmic extensions.
Our scRNA-seq analysis shows that genes regulating cell growth,
extracellular matrix organization, and angiogenesis are up-regulated
in Hopx+Igfbp2+ AT1 cells compared with Hopx+Igfbp2−AT1 cells
among P3, P15, and P60 lungs. In addition, Hopx+Igfbp2+AT1 cells
do not proliferate and do not transdifferentiate into AT2
cells during alveologenesis. All these results support our con-
clusion that Igfbp2 is an informative and highly specific genetic
marker for the terminal differentiation of AT1 cells.
Igfbp2’s function in AT1 development remains to be elucidated.
It belongs to an evolutionarily conserved IGFBP superfamily.
Many studies support that IGFBPs promote growth through both
IGF-dependent and IGF-independent mechanisms (32, 33). We
generated Igfbp2 null (Igfbp−/−) mice and conducted exploratory
functional analysis of Igfbp2 in AT1 cells. We found that Igfbp2−/−
mice are healthy and fertile, and H&E staining showed no obvious
differences between the lungs of Igfbp2−/− and littermate control
mice at 12 mo of age (SI Appendix, Fig. S8). One explanation for
this lack of any obvious phenotype is that multiple IGFBP family
members expressed in AT1 cells may play redundant functions in
regulating AT1 cell functions. It is notable that the cellular lo-
calization of IGFBP2 is different between human AT1 cells and
mouse AT1 cells. Both mouse Igfbp2 and human IGFBP2 contain
a nuclear localization signal. However, we found that only human
IGFBP2 is localized in the nucleus of AT1 cells. Thus, it is clear
that future investigations will need to precisely define the bio-
molecular function or functions of IGFBP2 and other IGFBP
family members in AT1 cells.
More and more evidence is suggesting that adult AT1 cells
have a variety of other functions beyond their known roles in the
formation of the air–blood barrier and in transporting ions and
water (14, 34, 35). Our study establishes that the AT1 cell pop-
ulation is actually composed of two distinct AT1 cell types during
alveolar development and during alveolar regeneration. This
knowledge and our demonstration of Igfbp2 as a robust and
reliable marker of the terminal differentiation of AT1 cells will
enable future investigation of the genetic and cellular mecha-
nisms that control the function of AT1 cells in development,
diseases, and lung regeneration.
Materials and Methods
A detailed description of the materials and methods used in the study is
provided in SI Appendix, SI Materials and Methods. Multiple mouse lines
were used. Primary AT1 and AT2 cells isolation, single-cell RNA-seq analysis,
immunostaining, pneumonectomy, lineage-tracing experiments, alveolar-
like organoid culture, and quantitative RT-PCR were performed. The data
reported in this paper have been deposited in the NCBI GEO database,
https://www.ncbi.nlm.nih.gov/geo/ (accession no. GSE106960).
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